NCT00857142View on ClinicalTrials.gov

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Pain

Interventions

DRUG

oxymorphone hydrochloride

DRUG

Opana

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sandoz

INDUSTRY